[Ebrotidine in the eradicating treatment of H. pylori].
M
M
Fernández Bermejo
R
R
García Grávalos
D000658:Amoxicillin / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000008:administration & dosage*; D017291:Clarithromycin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006635:Histamine H2 Antagonists / Q000008:administration & dosage*; D006801:Humans; D008875:Middle Aged; D010406:Penicillins / Q000008:administration & dosage; D013844:Thiazoles / Q000008:administration & dosage*; D013997:Time Factors
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D001557:Benzenesulfonates; D006635:Histamine H2 Antagonists; D010406:Penicillins; D013844:Thiazoles; D000658:Amoxicillin; D017291:Clarithromycin; C075156:ebrotidine